We are live on ! Find out more
CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Delisted

CPXX was delisted on the 11th of July, 2016.

Back to rankings

58 hedge funds and large institutions have $214M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2016 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,634% more capital invested

Capital invested by funds: $7.81M → $214M (+$206M)

617% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 6

500% more funds holding in top 10

Funds holding in top 10: 1 → 6 (+5)

176% more funds holding

Funds holding: 21 → 58 (+37)

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

95% less call options, than puts

Call options by funds: $39K | Put options by funds: $788K

Holders
58
Holders Change
+37
Holders Change %
+176.19%
% of All Funds
1.55%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.16%
New
43
Increased
8
Reduced
5
Closed
6
Calls
$39K
Puts
$788K
Net Calls
-$749K
Net Calls Change
-$749K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$4.75M
2
ACA
Avoro Capital Advisors
New York
+$4.64M
3
RCM
RA Capital Management
Massachusetts
+$4.64M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.46M
5
PA
Perceptive Advisors
New York
+$3.61M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.02M
2
Bank of America
Bank of America
North Carolina
-$180K
3
NC
Nexthera Capital
New York
-$158K
4
HF
Hoxton Financial
West Virginia
-$84K
5
FWM
Frontier Wealth Management
Missouri
-$71K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Caxton Corporation
New Jersey
$25.6M +$250K +76,300 +3%
VAM
2
Visium Asset Management
New York
$16M +$4.75M +1,450,000 New
ACA
3
Avoro Capital Advisors
New York
$15.6M +$4.64M +1,416,257 New
RCM
4
RA Capital Management
Massachusetts
$15.6M +$4.64M +1,414,114 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$15M +$4.46M +1,361,405 New
PA
6
Perceptive Advisors
New York
$12.1M +$3.61M +1,100,000 New
EC
7
EcoR1 Capital
California
$10.5M +$3.11M +950,000 New
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$9.38M +$2.79M +850,000 New
BC
9
Boxer Capital
California
$9.21M +$2.74M +835,408 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$8.92M +$892K +272,236 +51%
BI
11
BVF Inc
California
$8.82M +$2.62M +800,000 New
First Eagle Investment Management
12
First Eagle Investment Management
New York
$8.17M +$421K +128,400 +21%
Millennium Management
13
Millennium Management
New York
$7.1M +$2.11M +643,802 New
CAM
14
Cormorant Asset Management
Massachusetts
$6.84M +$2.03M +620,000 New
EI
15
EAM Investors
California
$6.06M +$1.8M +549,455 New
ACP
16
Acuta Capital Partners
California
$5.51M +$1.64M +500,000 New
DCM
17
Driehaus Capital Management
Illinois
$3.97M +$1.18M +359,682 New
EAM
18
EverPoint Asset Management
Connecticut
$3.31M +$983K +300,000 New
SCM
19
Sio Capital Management
New York
$2.69M +$798K +243,475 New
TCM
20
Tekla Capital Management
Massachusetts
$2.6M +$774K +236,000 New
Ameriprise
21
Ameriprise
Minnesota
$2.04M +$606K +184,771 New
OAM
22
Oxford Asset Management
United Kingdom
$2.01M +$597K +182,077 New
CS
23
Candriam SCA
Luxembourg
$1.81M +$541K +165,000 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$1.38M +$411K +125,432 New
RFC
25
Russell Frank Company
Washington
$1.35M +$401K +122,376 New
1
2 3

CPXX Hedge Fund Activity: Q1 2016 in Review

58 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q1 2016, worth a combined $214M — up 2,634% from $7.81M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new CPXX positions and 6 closed out — a net gain of 37 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $4.75M. The largest seller was Sabby Management, cutting an estimated $1.02M.

  • 58 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q1 2016, up from 21 in Q4 2015.
  • Funds reported $214M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q1 2016, up 2,634% quarter-over-quarter.
  • 43 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q1 2016 and 6 closed out, a net change of +37 holders.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q1 2016 was Visium Asset Management, an estimated $4.75M added.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q1 2016 was Sabby Management, an estimated $1.02M sold.

Based on aggregated 13F filings for Q1 2016.